Workflow
Tensions flare as Wingtech slams chipmaker Nexperia's head office over deception
Yahoo Finance· 2025-11-28 17:30
A fierce war of words has erupted between Dutch chipmaker Nexperia and its Chinese owner, Wingtech Technology, after China and the European Union signalled that their dispute should be resolved at the corporate level. Wingtech accused Nexperia's head office of being insincere after the Dutch head office publicly released a letter that said the chipmaker's Chinese unit had been unresponsive to requests for talks. The heightened tensions underscore the complexity in resolving the two sides' dispute over th ...
ACWI: Core Global Equities Strategy
Seeking Alpha· 2025-11-28 17:30
Monte Independent Investment Research: Michael Del Monte is a buy-side equity analyst with expertise in the technology, energy, industrials, and materials sectors. Prior to working in the investment management industry, Michael spent over a decade in professional services working across industries that include O&G, OFS, Midstream, Industrials, Information Technology, EPC Services, and consumer discretionary.Analyst’s Disclosure:I/we have a beneficial long position in the shares of NVDA either through stock ...
Meituan slides into loss in 'milk tea' subsidy war with instant commerce rival Alibaba
Yahoo Finance· 2025-11-28 17:30
China's food-delivery giant Meituan swung to a deep quarterly loss, as a costly battle with Alibaba Group Holding's instant commerce business eroded margins and kept revenue growth modest. The Beijing-based company on Friday reported revenue of 95.5 billion yuan (US$13.3 billion) for the three months to September, up 2 per cent year on year, missing analysts' estimates of 97.5 billion yuan. However, it booked an operating loss of 19.8 billion yuan, compared with a 13.7 billion yuan operating profit a yea ...
Surge in Hong Kong dollar bonds to continue after record US$42 billion year
Yahoo Finance· 2025-11-28 17:30
Hong Kong dollar bond issuance is poised to expand, following a record run of offerings, as easing local interest rates attract more issuers while a global diversification trend persists, according to analysts. Total issuance in the city's currency reached a record HK$331 billion (US$42.6 billion) so far this year, nearly 37 per cent higher than 2024's full-year total of HK$242 billion. "The Hong Kong dollar bond market will continue to grow over the long term, supported by structural shifts," said Olive ...
Is CME Group Stock Outperforming the Nasdaq?
Yahoo Finance· 2025-11-28 17:28
CME Group Inc. (CME) is a major force in global finance, a Chicago-based titan that has grown into the world’s preeminent arena for derivatives trading. What began as separate, historic exchanges has evolved into a unified powerhouse, bringing together the Chicago Mercantile Exchange, Chicago Board of Trade, NYMEX, and COMEX under one formidable umbrella. From interest rates and equities to currencies, energy, agriculture, and precious metals, CME Group serves as the silent engine behind markets that neve ...
Vuzix Stock: OEM Traction And Defense Momentum Grow, But I’m Staying On Hold (NASDAQ:VUZI)
Seeking Alpha· 2025-11-28 17:28
Vuzix Corporation ( VUZI ) is doing some good work around waveguides and OEM supply these days, and it’s starting to look like the company knows where its real opportunity sits. Going off the latest numbers and management’s discussions during the last earningsI’m Emmanuel Onwusah—a financial analyst, writer, and recovering engineer. I hold FMVA® and BIDA® certifications from the Corporate Finance Institute, and I spend most of my time creating pitch decks, building models, analyzing companies, and trying to ...
Vuzix: OEM Traction And Defense Momentum Grow, But I'm Staying On Hold
Seeking Alpha· 2025-11-28 17:28
Vuzix Corporation ( VUZI ) is doing some good work around waveguides and OEM supply these days, and it’s starting to look like the company knows where its real opportunity sits. Going off the latest numbers and management’s discussions during the last earningsI’m Emmanuel Onwusah—a financial analyst, writer, and recovering engineer. I hold FMVA® and BIDA® certifications from the Corporate Finance Institute, and I spend most of my time creating pitch decks, building models, analyzing companies, and trying to ...
Elon Musk's Tesla Is Offering Free FSD Rides To Customers In Europe Ahead Of February 2026 Deployment - Tesla (NASDAQ:TSLA)
Benzinga· 2025-11-28 17:27
特斯拉FSD技术欧洲推广 - 公司在欧洲多国为顾客提供免费的监督式全自动驾驶试乘服务,为明年该技术在该地区的部署做准备 [1] - 免费试乘活动将持续至年底,覆盖德国、法国、意大利的主要城市,包括柏林、巴黎、罗马等 [2] - 试乘活动由公司团队进行,向乘客展示FSD在实际路况下的工作方式,乘客位于副驾驶位,驾驶员为特斯拉员工 [3] 监管进展与技术发展 - 荷兰车辆管理局正与公司合作,以寻求FSD技术在该地区部署的监管批准,并证实了2026年2月的时间表 [4] - 特斯拉股东Ross Gerber称赞FSD v14.2版本的更新,认为其较之前版本有改进 [5] - 公司首席执行官暗示FSD v14.3更新可能实现无监督自动驾驶,称其为该技术的最后一块拼图 [5] 欧洲市场销售表现 - 10月公司在欧洲市场的新车注册量为6,964辆,同比大幅下降48.5% [6] - 公司今年1月至10月在欧洲市场的累计注册量为180,688辆,同比下降29.6% [6] 股票表现与公司评分 - 公司股价上涨1.71%,收于426.58美元 [7] - 公司在动量指标上得分良好,在质量和增长方面表现令人满意,但在价值方面表现不佳 [7]
Aegon evaluates selling operations outside the US
Yahoo Finance· 2025-11-28 17:23
Aegon is considering a divestment strategy outside of the US as part of a review aimed at sharpening business focus on its largest market, reported Bloomberg, citing sources. The Dutch insurer, which generates most of its earnings from US operations, is working with financial advisers to assess which international units could be sold, the source said. Aegon UK, responsible for administering retirement accounts, is among the divisions being examined for a potential sale. Additionally, the possibility of ...
Is Bristol-Myers Stock Underperforming the S&P 500?
Yahoo Finance· 2025-11-28 17:21
New Jersey-based Bristol-Myers Squibb Company (BMY) is a global biopharmaceutical giant focused on discovering, developing and delivering innovative medicines for serious diseases, with core areas including oncology, immunology, cardiovascular conditions and blood disorders. Bristol-Myers Squibb commands a powerful presence in oncology, led by blockbuster immuno-oncology therapies including Opdivo, Opdivo Qvantig, and Yervoy, among others. With a market capitalization of around $100.3 billion, Bristol-Mye ...